Citation Tools

Extended report
Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs

Download to a citation manager

Cite this article as:
Charles-Schoeman C, Burmester G, Nash P, et al
Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs